UNH icon

UnitedHealth

409.23 USD
-10.77
2.56%
At close Apr 29, 4:00 PM EDT
After hours
409.30
+0.07
0.02%
1 day
-2.56%
5 days
-4.18%
1 month
-21.87%
3 months
-23.95%
6 months
-27.20%
Year to date
-18.89%
1 year
-16.32%
5 years
42.27%
10 years
260.21%
 

About: UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Employees: 400,000

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

126% more first-time investments, than exits

New positions opened: 429 | Existing positions closed: 190

5% more funds holding

Funds holding: 3,418 [Q3] → 3,583 (+165) [Q4]

5% more call options, than puts

Call options by funds: $5.58B | Put options by funds: $5.31B

0.79% more ownership

Funds ownership: 86.79% [Q3] → 87.57% (+0.79%) [Q4]

7% less repeat investments, than reductions

Existing positions increased: 1,362 | Existing positions reduced: 1,464

11% less capital invested

Capital invested by funds: $465B [Q3] → $412B (-$53.2B) [Q4]

37% less funds holding in top 10

Funds holding in top 10: 311 [Q3] → 197 (-114) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$510
25%
upside
Avg. target
$558
36%
upside
High target
$650
59%
upside

10 analyst ratings

10 positive
100%
neutral
0%
negative
0%
Baird
Michael Ha
41% 1-year accuracy
9 / 22 met price target
25%upside
$510
Outperform
Maintained
29 Apr 2025
Barclays
Andrew Mok
40% 1-year accuracy
24 / 60 met price target
25%upside
$513
Overweight
Maintained
24 Apr 2025
JP Morgan
Lisa Gill
67% 1-year accuracy
16 / 24 met price target
28%upside
$525
Overweight
Maintained
24 Apr 2025
RBC Capital
Ben Hendrix
31% 1-year accuracy
22 / 70 met price target
28%upside
$525
Outperform
Maintained
23 Apr 2025
Morgan Stanley
Ricky Goldwasser
43% 1-year accuracy
6 / 14 met price target
38%upside
$563
Overweight
Maintained
22 Apr 2025

Financial journalist opinion

Based on 130 articles about UNH published over the past 30 days

Negative
Seeking Alpha
3 hours ago
UnitedHealth Group: Mr. Market Has Got It All Wrong
UnitedHealth's stock tanked following the Q1 earnings report after the company revised the earnings guidance for this year. Upon closer evaluation, it is evident that the challenges faced by the company are likely to be short-lived. The company is cheaply valued from a historical perspective, which does not make a lot of sense given strong growth expectations for the next five years.
UnitedHealth Group: Mr. Market Has Got It All Wrong
Positive
Seeking Alpha
5 hours ago
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetrated markets with potential FDA approval for Thunderbolt device as a growth catalyst.
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Positive
Seeking Alpha
5 hours ago
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts.
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Neutral
24/7 Wall Street
8 hours ago
Got $5,000: These Dividend Stocks Trade at a 52 Week Low
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today.
Got $5,000: These Dividend Stocks Trade at a 52 Week Low
Positive
Benzinga
1 day ago
Top 3 Health Care Stocks That May Rocket Higher In April
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Top 3 Health Care Stocks That May Rocket Higher In April
Neutral
Reuters
1 day ago
Corporate America boosts security spending after UnitedHealth murder, filings show
U.S. corporations have been ramping up their security spending, but following the murder of UnitedHealth executive Brian Thompson that expenditure is set to rise further in 2025 as more companies see heightened threats to their top brass.
Corporate America boosts security spending after UnitedHealth murder, filings show
Neutral
GlobeNewsWire
2 days ago
UNH Announcement: If You Have Suffered Losses in UnitedHealth Group Incorporated (NYSE: UNH) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of UnitedHealth Group Incorporated (NYSE: UNH) resulting from allegations that UnitedHealth may have issued materially misleading business information to the investing public.
UNH Announcement: If You Have Suffered Losses in UnitedHealth Group Incorporated (NYSE: UNH) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Positive
Schwab Network
4 days ago
ABBV Earnings Beat, Exposure to Tariffs, ABBV & UNH Options Trades
David Kaplan says AbbVie (ABBV) shows "unusually strong growth compared to peers." While he notes parts of its business is exposed to tariffs, the pharmaceutical and medical device industries are typically resilient to macro headwinds, and he believes AbbVie can withstand most.
ABBV Earnings Beat, Exposure to Tariffs, ABBV & UNH Options Trades
Negative
Seeking Alpha
5 days ago
UnitedHealth Group: Why I Never, Ever Use Stop Loss Orders
UnitedHealth Group Incorporated's Q1 earnings report led to a stock drop due to a $2 billion revenue miss and lowered EPS guidance, despite a 10% YoY revenue increase. UNH faces challenges from unexpected medical service demand and changes in Optum Health member profiles, impacting its quant ratings and growth outlook. Despite short-term unpredictability, the margin of safety has increased, presenting potential long-term attractiveness for risk-tolerant investors as EPS is expected to normalize by 2026.
UnitedHealth Group: Why I Never, Ever Use Stop Loss Orders
Neutral
Accesswire
5 days ago
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Inquire About Securities Class Action Investigation - UNH
NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / WHY: New York, N.Y., April 24, 2025.
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Inquire About Securities Class Action Investigation - UNH
Charts implemented using Lightweight Charts™